Overall, we show that bortezomib-resistant constitutive NF-κB activity is frequently observed in primary MCL samples, suggesting that nonproteasome-dependent mechanisms, including the PIR pathway, may be relevant to MCL biology. Here, PIR is linked to mantle cell lymphoma.